hearing loss
UK Provides £1.4M in Funding for Two-Year Study on Genedrive Test to Prevent Newborn Hearing Loss
The Manchester University NHS Foundation Trust will study across the UK the use of Genedrive's MT-RNR1 ID Kit as a pharmacogenomic test to prevent hearing loss.
NICE Recommends Genedrive Test in Draft Guidance to Prevent Hearing Loss in Newborns
NICE recommended that Genedrive's MT-RNR1 ID Kit should be adopted by the NHS for the prevention of antibiotic-induced hearing loss.
UK's NICE to Accelerate Assessment of Genedrive Test
NICE plans to assess Genedrive's MT-RNR1 test for antibiotics-induced hearing loss in infants via a new program.
The assay and point-of-care device were implemented in a trial in cooperation with clinical partners based at Manchester University NHS Foundation Trust.
Genedrive Expects CE-IVD Mark for POC SARS-CoV-2 Test by Fall; Advances Hearing Loss, HCV Assays
Premium
The Manchester, UK-based company had previously planned to have a CE-IVD marked test out by June 30.
Aug 23, 2019
Jun 12, 2019
Apr 11, 2018